Dracaena cochinchinensis
Dracaena cochinchinensis
Dracaena cochinchinensis, commonly known as dragon's blood, originates from traditional medicine practices. While its specific use varies across different cultures, it is not traditionally documented for any particular ailments or conditions. Scientific studies have identified eight new flavonoids in the plant, with three compounds showing promise in reducing protein expression levels associated with renal fibrosis in cell culture models. Additionally, dragon's blood has been observed to improve cardiac function by promoting lymphangiogenesis in heart failure models. Borneol, one of the 96 identified compounds, enhances brain penetration and facilitates metabolic transformations. (-)-dracaenolignan A (1) demonstrates significant potential as an antidepressant by alleviating neuroinflammation and depression-like behaviors in mice. No major safety issues or drug interactions have been recorded for this plant, but further research is needed to fully understand its therapeutic applications and potential effects.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- The study identified eight new flavonoids from Dracaena cochinchinensis and found that three of these compounds reduced protein expression levels related to renal fibrosis in cell cultures.
- Dragon's blood improved cardiac function in heart failure models through the promotion of cardiac lymphangiogenesis.
- A total of 96 compounds were identified in dragon's blood, with Borneol enhancing brain penetration and facilitating unique metabolic transformations.
- (-)-dracaenolignan A (1) shows potential as an antidepressant by alleviating neuroinflammation and depression-like behaviors in mice.
Frequently asked questions
What is Dracaena cochinchinensis?
Dracaena cochinchinensis (Dracaena cochinchinensis) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Dracaena cochinchinensis?
4 sourced findings are recorded for Dracaena cochinchinensis; the strongest carries evidence grade D. For example: The study identified eight new flavonoids from Dracaena cochinchinensis and found that three of these compounds reduced protein expression levels related to renal fibrosis in cell cultures.
How strong is the evidence for Dracaena cochinchinensis?
The strongest finding for Dracaena cochinchinensis carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Dracaena cochinchinensis safe? What are the side effects?
No major safety issues are recorded for Dracaena cochinchinensis in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Dracaena cochinchinensis interact with medications?
No drug interactions are recorded for Dracaena cochinchinensis in our sources. This does not rule them out — check with a pharmacist.
What are the common names of Dracaena cochinchinensis?
Dracaena cochinchinensis is also known as: Драцена кохинхинская.
Is Dracaena cochinchinensis a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Dragon's blood and its active components ameliorate pressure overload-induced heart failure via remodeling of cardiac lymphatics. literature abstract metadata
- T2 Skeletal Stilbenolignan Enantiomers and Flavonoid Derivatives Against Depression in Mice from Dracaena cochinchinensis Exudates. literature abstract metadata
- T2 Dracacochins A-H, undescribed flavonoid dimers and monomers from the red resin of Dracaena cochinchinensis and their anti-renal fibrosis activities. literature abstract metadata
- T2 Unveiling the Brain-Penetrating Material Basis of Dragon's Blood: Identification of Active Metabolites and Metabolic Pathways for Ischemic Stroke Therapy. literature abstract metadata